Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01889537 · ClinicalTrials.gov registry record · Phase 2
Low Dose Ketamine VR Analgesia During Burn Care Procedure
A Phase 2 study, sponsored by National Institute of General Medical Sciences (NIGMS).
- Completed
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT01889537 is a Phase 2 study that has completed, run by National Institute of General Medical Sciences (NIGMS). The registered enrollment target is 3 participants.
The verdict
NCT01889537, a Phase 2 study, has completed, sponsored by National Institute of General Medical Sciences (NIGMS).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of the research is to see whether a low dose of ketamine, a medication used to reduce pain, enhances the effectiveness of a virtual reality video game, which is used as a form of distraction from pain during a painful burn care procedure.
Interventions
- BEHAVIORAL Virtual Reality
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01889537
The ClinicalTrials.gov registry entry for NCT01889537 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of General Medical Sciences (NIGMS), which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Virtual Reality is the first listed.
NCT01889537 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01889537 about?
NCT01889537 is a clinical study titled "Low Dose Ketamine VR Analgesia During Burn Care Procedure". The purpose of the research is to see whether a low dose of ketamine, a medication used to reduce pain, enhances the effectiveness of a virtual reality video game, which is used as a form of distraction from pain during a painful burn care procedure.
What is the current status of trial NCT01889537?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2012-07. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01889537?
The interventions under investigation include: Virtual Reality (BEHAVIORAL).
Who is sponsoring clinical trial NCT01889537?
This trial is sponsored by National Institute of General Medical Sciences (NIGMS), which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.